Covid-19 News

    Quote from Fm1

    "We got to the point of a suspension because several European countries, including Germany and France, preferred to interrupt vaccinations... to put them on hold in order to carry out checks. The choice is a political one," Nicola Magrini told daily la Repubblica in an interview.

    For this purpose nobody should use the Pfizer vaccine anymore. As said 23 deaths within a week in Norway > 10 young health personal did die in the USA all with no precondition.

    It's all about corruption. Who pays more gets more! Astra Zeneca is the cheapest vaccine so far.

    What about the 10'000 narcolepsy cases of Pandermix?

    Either we a pandemic or we have a normal health care situation.


    So the state paid killers now can choose their weapon: Suppress Ivermectin, give the people the more deadly RNA vaccine or simply wait for more high income ICU victims by not giving people FP98 masks - the only that work.

    Watch the video I just posted

    • Official Post

    From 'Nature;...


    https://blogs.sciencemag.org/p…39373-455ce4eb5f-44567417


    What is Going on With the AstraZeneca/Oxford Vaccine?


    By Derek Lowe 16 March, 2021

    Everyone will have heard of the situation in Europe right now, with a whole list of countries suspending dosing of the AstraZeneca/Oxford vaccine. Sweden and Latvia joined that list today .But getting clarity on this is another thing entirely.

    I have not been the biggest fan of the vaccine, because its initial rollout was (frankly) botched. It was difficult to figure out how efficacious it was, and that confusion persisted after further attempts to clear things up. The last figure I’ve seen is that the European Medicines Agency estimates the vaccine to be about 60% effective, and at the same time the EMA does not see safety concerns with it. But there are many member states of the EU who apparently disagree, citing reports of blood clotting problems and/or thrombocytopenia after dosing.

    I haven't looked at AtroZ ... but I bet it's the PEG (Polyethyline Glycol) carrier, which affects clotting.

    First googal https://pubmed.ncbi.nlm.nih.gov/10924260/ ... too many technowords for me to figure out what's good or bad.


    Edit :


    Bit lower : The Oxford-AstraZeneca vaccine does not contain PEG, so those with allergies to this ingredient can receive the alternative vaccine.


    And lower : This is due to the rejection that some people have to a product included in the messenger RNA vaccines (Pfizer and Moderna), the Polyethylene glycol (PEG). The AstraZeneca vaccine contains Polysorbate 80 (similar to PEG), and in this case it is responsible for the allergic reaction.

    Edit 2 :

    “Clinical studies have shown darbepoetin alfa (polysorbate 80) to increase the risk of serious side effects (eg, blood clots, stroke, heart attack, heart failure) and death in some cases.


    Crackpotty source ?: https://olis.leg.state.or.us/l…teeMeetingDocument/168450

    Alan, it's started!


    Bitcoin ATMs are coming to a gas station near you

    https://www.foxbusiness.com/ma…to-a-gas-station-near-you

    There is an interesting discussion on Twitter on a new hypothesis that links the 7 recently reported sinus vein thrombosis cases in Germany to a spontaneous heparin-induced thrombocytopenia syndrome. Interesting read and discussion there, maybe a potential unforseen root cause why young healthy people suddenly face such severe problems....?


    Heparin Induced Thrombocytopenia (HIT) is theorized here to be the cause of 7 cases of Sinus Venous Thrombosis (blood clots in veins that drain blood from the brain) related to the AstraZeneca #COVID19 vaccine.

    External Content twitter.com
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.


    https://www.tandfonline.com/do…3109/09537104.2014.979338

    Promising At-Home Treatment for COVID-19 Discovered: FDA Approved Drug for Leprosy


    https://scitechdaily.com/promi…ved-drug-for-leprosy/amp/



    Promising At-Home Treatment for COVID-19 Discovered: FDA Approved Drug for Leprosy

    By Sanford Burnham Prebys Medical Discovery Institute on Mar 16, 2021

    Laura Martin-Sancho


    Testing in the lab at Sanford Burnham Prebys Medical Discovery Institute. Credit: Sanford Burnham Prebys Medical Discovery Institute


    Phase 2 clinical trial could begin immediately for clofazimine, an FDA-approved drug on WHO’s List of Essential Medicines.


    A Nature study authored by scientists at Sanford Burnham Prebys Medical Discovery Institute and the University of Hong Kong shows that the leprosy drug clofazimine, which is FDA approved and on the World Health Organization’s List of Essential Medicines, exhibits potent antiviral activities against SARS-CoV-2 and prevents the exaggerated inflammatory response associated with severe COVID-19. Based on these findings, a Phase 2 study evaluating clofazimine as an at-home treatment for COVID-19 could begin immediately.


    “Clofazimine is an ideal candidate for a COVID-19 treatment. It is safe, affordable, easy to make, taken as a pill and can be made globally available,” says co-senior author Sumit Chanda, Ph.D., professor and director of the Immunity and Pathogenesis Program at Sanford Burnham Prebys. “We hope to test clofazimine in a Phase 2 clinical trial as soon as possible for people who test positive for COVID-19 but are not hospitalized. Since there is currently no outpatient treatment available for these individuals, clofazimine may help reduce the impact of the disease, which is particularly important now as we see new variants of the virus emerge and against which the current vaccines appear less efficacious.”


    Virologist Sumit Chanda


    Sumit Chanda, Ph.D., a professor at Sanford Burnham Prebys Medical Discovery Institute, gestures to experimental assays that test for compounds that may treat COVID-19. Credit: Sanford Burnham Prebys Medical Discovery Institute


    Promising candidate revealed by screening drug library

    Clofazimine was initially identified by screening one of the world’s largest collections of known drugs for their ability to block the replication of SARS-CoV-2. Chanda’s team previously reported in Nature that clofazimine was one of 21 drugs effective in vitro, or in a lab dish, at concentrations that could most likely be safely achieved in patients.


    In this study, the researchers tested clofazimine in hamsters–an animal model for COVID-19–that were infected with SARS-CoV-2. The scientists found that clofazimine lowered the amount of virus in the lungs, including when given to healthy animals prior to infection (prophylactically). The drug also reduced lung damage and prevented “cytokine storm,” an overwhelming inflammatory response to SARS-CoV-2 that can be deadly.


    “The animals that received clofazimine had less lung damage and lower viral load, especially when receiving the drug before infection,” says co-senior author Ren Sun, Ph.D., professor at the University of Hong Kong and distinguished professor emeritus at the University of California, Los Angeles (UCLA). “Besides inhibiting the virus, there are indications that the drug also regulates the host response to the virus, which provides better control of the infection and inflammation.”


    Clofazimine also worked synergistically with remdesivir, the current standard-of-care treatment for people who are hospitalized due to COVID-19, when given to hamsters infected with SARS-CoV-2. These findings suggest a potential opportunity to stretch the availability of remdesivir, which is costly and in limited supply.

    Collapsing COVID: MIT Says Ultrasound Can Damage Coronaviruses


    https://scitechdaily.com/colla…damage-coronaviruses/amp/


    Simulations show ultrasound waves at medical imaging frequencies can cause the virus’ shell and spikes to collapse and rupture.


    The coronavirus’ structure is an all-too-familiar image, with its densely packed surface receptors resembling a thorny crown. These spike-like proteins latch onto healthy cells and trigger the invasion of viral RNA. While the virus’ geometry and infection strategy is generally understood, little is known about its physical integrity.


    A new study by researchers in MIT’s Department of Mechanical Engineering suggests that coronaviruses may be vulnerable to ultrasound vibrations, within the frequencies used in medical diagnostic imaging.


    Through computer simulations, the team has modeled the virus’ mechanical response to vibrations across a range of ultrasound frequencies. They found that vibrations between 25 and 100 megahertz triggered the virus’ shell and spikes to collapse and start to rupture within a fraction of a millisecond. This effect was seen in simulations of the virus in air and in water.


    The results are preliminary, and based on limited data regarding the virus’ physical properties. Nevertheless, the researchers say their findings are a first hint at a possible ultrasound-based treatment for coronaviruses, including the novel SARS-CoV-2 virus. How exactly ultrasound could be administered, and how effective it would be in damaging the virus within the complexity of the human body, are among the major questions scientists will have to tackle going forward.


    “We’ve proven that under ultrasound excitation the coronavirus shell and spikes will vibrate, and the amplitude of that vibration will be very large, producing strains that could break certain parts of the virus, doing visible damage to the outer shell and possibly invisible damage to the RNA inside,” says Tomasz Wierzbicki, professor of applied mechanics at MIT. “The hope is that our paper will initiate a discussion across various disciplines.”

    so now it appears that once you test positive, it your responsibility to find a treatment. Confusion continues to rule!!! Deflect blame, now it's the patients fault for no treatment


    Why coronavirus patients aren't getting a promising treatment


    https://www.axios.com/coronavi…f8-bfc8-b53fd18cf441.html


    Only a minority of patients are receiving some of the most promising coronavirus treatments.


    Why it matters: COVID-19 is almost certainly going to be part of our lives for a long time, even with high vaccination rates. Antibody treatments could make it much less deadly — but only if patients get them.


    Driving the news: Two still-unpublished studies found that two specific antibody therapies can prevent hospitalization and death among high-risk people with mild or moderate COVID-19 infections, Nature reports.


    An antibody developed by Vir Biotechnology and GSK reduced the likelihood of hospitalization or death among clinical trial participants by 85%.

    The second, an antibody cocktail developed by Eli Lilly, reduced the risk of hospitalization and death by 87%.

    “It is not a replacement for vaccines, but it is a plan B,” Jens Lundgren, an infectious-disease physician at the University of Copenhagen and Rigshospitalet, told Nature.

    Yes, but: Only about 1 in every 6 or 7 coronavirus patients eligible to receive antibody treatments are actually receiving them, said Janelle Sabo, who leads COVID-19 therapeutics at Lilly.


    That’s an improvement from December and January, when only 1 of every 20 to 30 high-risk patients were receiving the treatments, she said.

    “The majority are not being treated with the neutralizing antibody, despite the wide availability of it,” Sabo said.

    The federal government put the number higher, saying that 37% of outpatients at high risk of developing severe symptoms and hospitalization nationally now receive the antibody therapies.


    "We are actively working to increase awareness of therapeutics and to provide them to more types of sites such as urgent care clinics, physician’s offices, and ambulatory infusion sites," an administration official said.

    How it works: Antibody therapies — like the Regeneron treatment that then-President Trump received when he caught the coronavirus — are most effective when they're administered early.


    That means patients would need test positive soon after they are infected. But people often don’t get tested until they are feeling sick, which could be too late.

    Once confirmed positive, a patient then has to have a conversation with a doctor who can connect that patient with a treatment center that infuses the therapies.

    “The issue is people aren’t going to their primary care physicians to get tested. They’re going to community centers and the pharmacy,” Sabo said. That “puts a burden on the patient that typically in the health care transaction they don’t have.”

    Finally, that patient has to get to the infusion center.

    The bottom line: “We still don’t know much about long haulers and reinfection rates and variants,” Sabo said. “I think it would be premature to say [COVID]’s become manageable if you’re not vaccinated.”


    Who set the system up? Test positive and go home and quarantine, that's what we were told !!!

    A good example of why americans distrust science


    Many scientists citing two scandalous COVID-19 papers ignore their retractions


    https://www.sciencemag.org/new…-ignore-their-retractions


    In June 2020, in the biggest research scandal of the pandemic so far, two of the most important medical journals each retracted a high-profile study of COVID-19 patients. Thousands of news articles, tweets, and scholarly commentaries highlighted the scandal, yet many researchers apparently failed to notice. In an examination of the most recent 200 academic articles published in 2020 that cite those papers, Science found that more than half—including many in leading journals—used the disgraced papers to support scientific findings and failed to note the retractions.


    COVID-19 “is such a hot topic that publishers are willing to publish without proper vetting,” even in the face of retractions that made global headlines, says Elizabeth Suelzer, a reference librarian at the Medical College of Wisconsin who has written about problematic citations to a retracted 1998 study in The Lancet falsely linking vaccination to autism.


    Both of the retracted COVID-19 papers, one in The New England Journal of Medicine (NEJM) and the other in The Lancet, were based on what appeared to be a huge database of patient records compiled from hospitals worldwide by Surgisphere, a small company operated by vascular surgeon Sapan Desai, who was a co-author on each article. The 22 May 2020 Lancet paper ostensibly showed that hydroxychloroquine, an antimalarial drug promoted by President Donald Trump and others, could harm rather than help COVID-19 patients. Its publication led to a temporary halt in a major clinical trial and inflamed an already-divisive debate over the drug, which has proved to be no help against COVID-19. The 1 May NEJM article corroborated other evidence that people already taking certain blood pressure medicines did not face a greater risk of death if they developed COVID-19.


    Questions soon arose about the validity, and even existence, of the Surgisphere database, however, and the retractions followed on 4 June. But of the 200 papers examined by Science—all published after the retractions—105 inappropriately cited one of the disgraced studies. In several cases it was a primary source for a meta-analysis combining multiple studies to draw overarching conclusions. In most, the studies were cited as scientific support or context. Science also found a handful of articles that uncritically cited an influential April preprint based on the same Surgisphere data set, which described the antiparasitic drug ivermectin as beneficial in critical COVID-19 cases. (There is no standard way to retract preprints, however.)


    Ivan Oransky, co-founder of the website Retraction Watch, says such blunders occur because “people are either willfully or negligently not checking references.” Many authors copy and paste lists of apparently relevant citations from similar papers without actually reading them, he says. “It’s frightening. It’s terrible, but common.”


    Many of the tainted citations appeared in papers published by little-known journals, but at least a dozen found their way into major publications. For example, three articles in PLOS ONE, the prominent open-access journal, cited the retracted papers in discussions of pandemic conditions in Europe. A 28 December paper in the Proceedings of the National Academy of Sciences (PNAS)—one of the most influential journals—discussed the risks and benefits of drugs to treat COVID-19 and noted the Lancet retraction in its citations, yet the text merely noted the paper’s hydroxychloroquine findings as “controversial.”

    Quote from Fm1

    They found that vibrations between 25 and 100 megahertz triggered the virus’ shell and spikes to collapse and start to rupture within a fraction of a millisecond.

    This is a hot research item also to fight some bacteria with vacuoles. May be to cheap like ivermectin and not applicable for deep body treatement.

    Quote from Fm1

    “The majority are not being treated with the neutralizing antibody, despite the wide availability of it,” Sabo said.

    The majority is not treated by Ivermectin the only drug that is harmless and works. If you live on India you can get it at the Kiosk.


    It is very telling to see how many criminal companies try to sell their useless dirt as CoV-19 drug. Gilead was just the first and most prominent one. Some criminal doctors still prescribe the Gilead crap remdesivir for a nice kickback albeit the WHO is against its use...

    But I have no mercy with all teh idiots that believe all doctors are here to help you. Yes a few of them - like Corry -still do help you. The other live of you. This profession - thanks to Harvard thinking - just has ethically collapsed.

    https://www.washingtonpost.com…c-e58213caa38e_story.html


    Some long-haul covid-19 patients say their symptoms are subsiding after getting vaccines



    Arianna Eisenberg endured long-haul covid-19 for eight months, a recurring nightmare of soaking sweats, crushing fatigue, insomnia, brain fog and muscle pain.

    But Eisenberg’s tale has a happy ending that neither she nor current medical science can explain. Thirty-six hours after her second shot of coronavirus vaccine last month, her symptoms were gone, and they haven’t returned.


    “I really felt back to myself,” the 34-year-old Brooklyn therapist said, “to a way that I didn’t think was possible when I was really sick.”


    Some people who have spent months suffering from long-haul covid-19 are taking to social media to report their delight at seeing their symptoms disappear after their vaccinations, leaving experts chasing yet another puzzling clinical development surrounding the disease caused by the coronavirus. . . .



    . . . When Survivor Corps informally surveyed its members recently, 216 people said they felt no different after vaccination, 171 said their conditions improved and 63 reported that they felt worse . . .

    Virus variants found to be deadlier, more contagious; some may thwart vaccines


    https://mobile.reuters.com/article/amp/idUSKBN2B92U7


    (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.


    Multiple variants can "escape" vaccines


    Antibodies induced by the Moderna Inc and Pfizer Inc/BioNTech SE vaccines are dramatically less effective at neutralizing some of the most worrying coronavirus variants, a new study suggests. Researchers obtained blood samples from 99 individuals who had received one or two doses of either vaccine and tested their vaccine-induced antibodies against virus replicas engineered to mimic 10 globally circulating variants. Five of the 10 variants were "highly resistant to neutralization," even when volunteers had received both doses of the vaccines, the researchers reported on Friday in Cell. All five highly resistant variants had mutations in the spike on the virus surface - known as K417N/T, E484K, and N501Y - that characterize a variant rampant in South Africa and two variants spreading rapidly in Brazil. In keeping with previous studies, the proportion of neutralizing antibodies dropped 5- to 6-fold against the variants discovered in Brazil. Against the variant discovered in South Africa, neutralization fell 20- to 44-fold. A variant circulating now in New York has the E484K mutation. "While studies of the New York variant are ongoing, our findings suggest that similar variants harboring E484K may be harder for vaccine-induced antibodies to neutralize," said study leader Alejandro Balazs of Harvard University and the Massachusetts General Hospital. "Despite our results," he added, "it's important to consider that vaccines raise other kinds of immune responses which could protect against developing severe disease." (bit.ly/3bWB1Ko)

    Two mouthwashes disrupt COVID-19 virus under laboratory conditions


    https://www.news-medical.net/a…aboratory-conditions.aspx


    Researchers at Rutgers School of Dental Medicine have found evidence that two types of mouthwash disrupt the COVID-19 virus under laboratory conditions, preventing it from replicating in a human cell.


    The study, published in the journal Pathogens, found that Listerine and the prescription mouthwash Chlorhexidine disrupted the virus within seconds after being diluted to concentrations that would mimic actual use. Further studies are needed to test real-life efficacy in humans.


    The study was conducted in a lab using concentrations of the mouthwash and the time it would take to contact tissues to replicate conditions found in the mouth, said Daniel H. Fine, the paper's senior author and chair of the school's Department of Oral Biology.


    The study found two other mouthwashes showed promise in potentially providing some protection in preventing viral transmission: Betadine, which contains povidone iodine, and Peroxal, which contains hydrogen peroxide. However, only Listerine and Chlorhexidine disrupted the virus with little impact on skin cells inside the mouth that provide a protective barrier against the virus.

    more smoke and mirrors from The WHO


    WHO Points To Wildlife Farms In Southern China As Likely Source Of Pandemic


    https://www.npr.org/sections/g…likely-source-of-pandemic


    A member of the World Health Organization investigative team says wildlife farms in southern China are the most likely source of the COVID-19 pandemic.


    China shut down those wildlife farms in February 2020, says Peter Daszak, a disease ecologist with EcoHealth Alliance and a member of the WHO delegation that traveled to China this year. During that trip, Daszak says, the WHO team found new evidence that these wildlife farms were supplying vendors at the Huanan Seafood Wholesale Market in Wuhan with animals.


    Daszak told NPR that the government response was a strong signal that the Chinese government thought those farms were the most probable pathway for a coronavirus in bats in southern China to reach humans in Wuhan.


    Those wildlife farms, including ones in the Yunnan region, are part of a unique project that the Chinese government has been promoting for 20 years now.


    "They take exotic animals, like civets, porcupines, pangolins, raccoon dogs and bamboo rats, and they breed them in captivity," says Daszak.


    The agency is expected to release the team's investigative findings in the next two weeks. In the meantime, Daszak gave NPR a highlight of what the team figured out.

    Well let's add this study to the hundreds of studys done over 40 years that confirms Vitamin D deficenccy in african americans . You would think that they would act on this but again the same phrase more study needs to be done.


    African Americans with Low Vitamin D Status Have Increased Covid-19 Risk


    https://www.wwltv.com/amp/arti…6f-47b2-b5ba-990218ac6bc0


    NEW ORLEANS — Based on epidemiology data, as to the higher incidence of risk to complications related to Covid-19 exposure in African Americans, science has been exploring a number of possible reasons.


    New research – Does the High Prevalence of Vitamin D deficiency in African Americans Contribute to Health Disparities – which appeared in the online, peer-reviewed journal Nutrients in February of 2021 – says there is a higher prevalence of Vitamin D deficiency in many African Americans – the result of people of African descent having brown-black melanin skin pigment, versus Angelo-Celtics, who have a yellow-to-reddish melanin.

    more accurate than tests


    Thai sniffer dogs can detect COVID-19 in sweat, project shows


    https://mobile.reuters.com/article/amp/idUSKBN2B91GX


    BANGKOK (Reuters) - Thai sniffer dogs trained to detect COVID-19 in human sweat proved nearly 95% accurate during training and could be used to identify coronavirus infections at busy transport hubs within seconds, the head of a pilot project said.


    Six Labrador Retrievers participated in a six-month project that included unleashing them to test an infected patient's sweat on a spinning wheel of six canned vessels.


    "The dogs take only one to two seconds to detect the virus," Professor Kaywalee Chatdarong, the leader of the project at the veterinary faculty of Thailand's Chulalongkorn University, told Reuters.

Subscribe to our newsletter

It's sent once a month, you can unsubscribe at anytime!

View archive of previous newsletters

* indicates required

Your email address will be used to send you email newsletters only. See our Privacy Policy for more information.

Our Partners

Supporting researchers for over 20 years
Want to Advertise or Sponsor LENR Forum?
CLICK HERE to contact us.